The 6 analysts offering 12-month price forecasts for HOOKIPA Pharma Inc have a median target of 5.00, with a high estimate of 7.00 and a low estimate of 3.00. The median estimate represents a +786.68% increase from the last price of 0.56.
The current consensus among 6 polled investment analysts is to Buy stock in HOOKIPA Pharma Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Mar 21
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.